«1234567»Seite
8 articles with references, page 2 of 8

Review article

MRI in Patients With Pacemakers: Overview and Procedural Management

Dtsch Arztebl Int 2012; 109(15): 270-5; DOI: 10.3238/arztebl.2012.0270

Bovenschulte, H; Schlüter-Brust, K; Liebig, T; Erdmann, E; Eysel, P; Zobel, C

1. Roguin A, Schwitter J, Vahlhaus C, et al.: Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336–46. CrossRef MEDLINE
2. Irnich W, Irnich B, Bartsch C, et al.: Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005; 7: 353–65. CrossRef MEDLINE
3. Sommer T, Naehle CP, Yang A, et al.: Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006; 114: 1285–92. CrossRef MEDLINE
4. Luechinger R, Zeijlemaker VA, Pedersen EM, et al.: In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005; 26: 376–83. CrossRef MEDLINE
5. Roguin A, Zviman MM, Meininger GR, et al.: Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004; 110: 475–82. CrossRef MEDLINE
6. Luechinger R, Duru F, Zeijlemaker VA, et al.: Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002; 25: 1419–23. CrossRef MEDLINE
7. Gimbel JR: Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a ’modern’ pacemaker. Europace 2009; 11: 1241–2. CrossRef MEDLINE
8. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL: Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005; 28: 1041–6. CrossRef MEDLINE
9. Naehle CP, Litt H, Lewalter T, Sommer T: Do we need pacemakers resistant to magnetic resonance imaging? Europace 2006; 8: 388. CrossRef MEDLINE
10. Sommer T, Vahlhaus C, Lauck G, et al.: MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000; 215: 869–79. MEDLINE
11. Schmiedel A, Hackenbroch M, Yang A, et al.: Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla. Rofo 2005; 177: 731–44. CrossRef MEDLINE
12. Martin ET, Coman JA, Shellock FG, et al.: Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43: 1315–24. CrossRef MEDLINE
13. Nazarian S, Roguin A, Zviman MM, et al.: Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114: 1277–84. CrossRef MEDLINE
14. Nazarian S, Hansford R, Roguin A, et al.: A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011; 155: 415–24. MEDLINE
15. Mollerus M, Albin G, Lipinski M, Lucca J: Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010; 12: 947–51. CrossRef MEDLINE
16. Strach K, Naehle CP, Muhlsteffen A, et al.: Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace 2010; 12: 952–60. CrossRef MEDLINE
17. Naehle CP, Meyer C, Thomas D, et al.: Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 2008; 249: 991–1001. CrossRef MEDLINE
18. Mollerus M, Albin G, Lipinski M, Lucca J: Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2008; 31: 1241–5. CrossRef MEDLINE
19. Naehle CP, Zeijlemaker V, Thomas D, et al.: Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol 2009; 32: 1526–35. CrossRef MEDLINE
20. Burke PT, Ghanbari H, Alexander PB, et al.: A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010; 28: 59–66. CrossRef MEDLINE
21. Naehle CP, Kreuz J, Strach K, et al.: Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J 2011; 161: 1096–105. CrossRef MEDLINE
22. Gimbel JR: Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol 2008; 31: 795–801. CrossRef MEDLINE
23. Langman DA, Goldberg IB, Finn JP, Ennis DB: Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging 2011; 33: 426–31. CrossRef MEDLINE
24. Wilkoff BL, Bello D, Taborsky M, et al.: Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011; 8: 65–73. CrossRef MEDLINE
25. Junttila MJ, Fishman JE, Lopera GA, et al.: Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011; 97: 1852–6. CrossRef MEDLINE
e1.Jahresbericht Deutsches Herzschrittmacher Register 2008
www.pacemakerregister.de/pdf/zentralregister_herzschrittmacher_ bericht08.pdf
e2.Trappe HJ, Gummert J: Current pacemaker and defibrillator therapy. Dtsch Arztebl Int 2011; 108: 372–9. VOLLTEXT
e3.Barmer GEK Arztreport 2011 www.barmergek.de/barmer/
web/Portale/ Versicherte/Komponenten/gemeinsame__ PDF__Dokumente/Reports/Arztreport-2011-PDF,property=Data.pdf
e4.Kalin R, Stanton MS: Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005; 28: 326–8. CrossRef MEDLINE
e5.Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R: Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001; 24: 199–205. MEDLINE
e6.Roguin A, Zviman MM, Meininger GR, et al.: Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004; 110: 475–82. MEDLINE
e7.Achenbach S, Moshage W, Diem B, et al.: Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997; 134: 467–73. MEDLINE
e8.Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE: Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998; 21: 1336–9. MEDLINE
e9.Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N: Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990. J Infect 1997; 34: 113–8. MEDLINE
e10.Woertgen C, Rothoerl RD, Englert C, Neumann C: Pyogenic spinal infections and outcome according to the 36-item short form health survey. J Neurosurg Spine 2006; 4: 441–6. CrossRef MEDLINE
e11.Faris OP, Shein M: Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006; 114: 1232–3. CrossRef MEDLINE